How Does Lowering of Intraocular Pressure Protect the Optic Nerve?

Survey of Ophthalmology

Volumn 53, Issue 6 SUPPL., 2008, Pages

  Mackenzie, Paul ^a   Cioffi, George ^a  

^a DEVERS EYE INSTITUTE   (United States)

Author keywords

fluctuation; glaucoma; intraocular pressure; susceptibility

Indexed keywords

ADRENALIN; ANTIGLAUCOMA AGENT; ANTIHYPERTENSIVE AGENT; BETAXOLOL; PILOCARPINE;

ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CLOSED ANGLE GLAUCOMA; DISEASE COURSE; DRUG EFFICACY; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; OPEN ANGLE GLAUCOMA; OPTIC NERVE; PRIORITY JOURNAL; TRABECULOPLASTY; VISUAL FIELD;

GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; OCULAR HYPERTENSION; OPTIC DISK; OPTIC NERVE DISEASES;

EID: 56449124760     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2008.08.008     Document Type: Article

References (39)

1. ___: The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol 126 (1998) 498-505
2. ___: Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol 126 (1998) 487-497
3. Bellezza A.J., Hart R.T., and Burgoyne C.F. The optic nerve head as a biomechanical structure: initial finite element modeling. Invest Ophthalmol Vis Sci 41 (2000) 2991-3000
4. Bengtsson B., Leske M.C., Hyman L., et al. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology 114 (2007) 205-209
5. Broadway D.C., Nicolela M.T., and Drance S.M. Optic disk appearances in primary open-angle glaucoma. Surv Ophthalmol 43 Suppl 1 (1999) S223-S243
6. Burgoyne C.F., Downs J.C., Bellezza A.J., et al. The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog Retin Eye Res 24 (2005) 39-73
7. Caprioli J., Coleman A.L., et al. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the Advanced Glaucoma Intervention Study. Ophthalmology 114 (2007) 1123-1129
8. Cioffi G.A. Ischemic model of optic nerve injury. Trans Am Ophthalmol Soc 103 (2005) 592-613
9. Cioffi G.A., Wang L., Fortune B., et al. Chronic ischemia induces regional axonal damage in experimental primate optic neuropathy. Arch Ophthalmol 122 (2004) 1517-1525
10. Drance S., Anderson D.R., Schulzer M., et al. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol 131 (2001) 699-708
11. Eddy D.M., Sanders L.E., and Eddy J.F. The value of screening for glaucoma with tonometry. Surv Ophthalmol 28 (1983) 194-205
12. Emre M., Orgül S., Haufschild T., et al. Increased plasma endothelin-1 levels in patients with progressive open angle glaucoma. Br J Ophthalmol 89 (2005) 60-63
13. Flammer J., Haefliger I.O., Orgül S., et al. Vascular dysregulation: a principal risk factor for glaucomatous damage?. J Glaucoma 8 (1999) 212-219
14. Gherghel D., Hosking S.L., and Cunliffe I.A. Abnormal systemic and ocular vascular response to temperature provocation in primary open-angle glaucoma patients: a case for autonomic failure?. Invest Ophthalmol Vis Sci 45 (2004) 3546-3554
15. Hayreh S.S., Zimmerman M.B., Podhajsky P., et al. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 117 (1994) 603-624
16. Heijl A., Leske M.C., Bengtsson B., et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120 (2002) 1268-1279
17. Hernandez M.R. The optic nerve head in glaucoma: role of astrocytes in tissue remodeling. Prog Retin Eye Res 19 (2000) 297-321
18. Holmin C., and Krakau C.E. Visual field decay in normal subjects and in cases of chronic glaucoma. Albrecht Von Graefes Arch Klin Exp Ophthalmol 213 (1980) 291-298
19. Kass M.A., Heuer D.K., Higginbotham E.J., et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120 (2002) 701-713 discussion 829-30
20. Lobsiger C.S., and Cleveland D.W. Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat Neurosci 10 (2007) 1355-1360
21. Maier P.C., Funk J., Schwarzer G., et al. Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials. BMJ 331 (2005) 134
22. Medeiros F.A., Weinreb R.N., Zangwill L.M., et al. Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma. Ophthalmology 114 (2007) 934-940
23. Miglior S., Zeyen T., Pfeiffer N., et al. Results of the European Glaucoma Prevention Study. Ophthalmology 112 (2005) 366-375
24. Minckler D.S., Bunt A.H., and Johanson G.W. Orthograde and retrograde axoplasmic transport during acute ocular hypertension in the monkey. Invest Ophthalmol Vis Sci 16 (1977) 426-441
25. Morgan J.E. Optic nerve head structure in glaucoma: astrocytes as mediators of axonal damage. Eye 14 Pt 3B (2000) 437-444
26. Morrison J.C. Integrins in the optic nerve head: potential roles in glaucomatous optic neuropathy (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 104 (2006) 453-477
27. Nicolela M.T., Ferrier S.N., Morrison C.A., et al. Effects of cold-induced vasospasm in glaucoma: the role of endothelin-1. Invest Ophthalmol Vis Sci 44 (2003) 2565-2572
28. Nicolela M.T., McCormick T.A., Drance S.M., et al. Visual field and optic disc progression in patients with different types of optic disc damage: a longitudinal prospective study. Ophthalmology 110 (2003) 2178-2184
29. Nouri-Mahdavi K., Hoffman D., Coleman A.L., et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 111 (2004) 1627-1635
30. Pache M., and Flammer J. A sick eye in a sick body? Systemic findings in patients with primary open-angle glaucoma. Surv Ophthalmol 51 (2006) 179-212
31. Parrish R.K. The European Glaucoma Prevention Study and the Ocular Hypertension Treatment Study: why do two studies have different results?. Curr Opin Ophthalmol 17 (2006) 138-141
32. Quigley H., and Anderson D.R. The dynamics and location of axonal transport blockade by acute intraocular pressure elevation in primate optic nerve. Invest Ophthalmol 15 (1976) 606-616
33. Quigley H.A. European Glaucoma Prevention Study. Ophthalmology 112 (2005) 1642-1643 author reply 1643-5
34. Quigley H.A., Hohman R.M., Addicks E.M., et al. Morphologic changes in the lamina cribrosa correlated with neural loss in open-angle glaucoma. Am J Ophthalmol 95 (1983) 673-691
35. Rossetti L., Marchetti I., Orzalesi N., et al. Randomized clinical trials on medical treatment of glaucoma. Are they appropriate to guide clinical practice?. Arch Ophthalmol 111 (1993) 96-103
36. Schwartz M. Neurodegeneration and neuroprotection in glaucoma: development of a therapeutic neuroprotective vaccine: the Friedenwald lecture. Invest Ophthalmol Vis Sci 44 (2003) 1407-1411
37. Tezel G., and Wax M.B. The immune system and glaucoma. Curr Opin Ophthalmol 15 (2004) 80-84
38. Wormald R. Treatment of raised intraocular pressure and prevention of glaucoma. BMJ 326 (2003) 723-724
39. Yang H., Downs J.C., Bellezza A., et al. 3-D histomorphometry of the normal and early glaucomatous monkey optic nerve head: prelaminar neural tissues and cupping. Invest Ophthalmol Vis Sci 48 (2007) 5068-5084